Curavit Clinical Research
Scarsdale, US · Founded 2019 · Delaware corporation · 49 employees on LinkedIn · 1 known investors
Founders & leadership
Curavit Clinical Research was founded in 2019 by Joel Morse.
JM
Joel MorseFounder
DH
David HanamanNamed on SEC filing
Board
JK
Jackie KentBoard director
RL
Rich LesterBoard director
NL
Nathanael LentzBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$11.4M disclosed across 1 round · 2022
▶$11.4MraisedSep 2024 · 30 investors · Other Health CareRule 506(b)
▶$11.4MraisedSep 2024 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jackie KentDirector
- Rich LesterDirector
- Joel MorseExecutive Officer, Director
- Nathanael LentzDirector
- David HanamanDirector
- Offering amount
- $11.6M
- Amount sold
- $11.4M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Curavit Clinical Research?
- Curavit Clinical Research was founded by Joel Morse in 2019.
- Who are Curavit Clinical Research's investors?
- Curavit Clinical Research's investors include Osage Venture Partners.
- How much funding has Curavit Clinical Research raised?
- Curavit Clinical Research has disclosed $11.4M raised across 1 round.
- Where is Curavit Clinical Research headquartered?
- Curavit Clinical Research is headquartered in Scarsdale, US.

